Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial. - LoRusso PM; Sekulic A; Sosman JA; Liang WS; Carpten J; Craig DW; Solit DB; Bryce AH; Kiefer JA; Aldrich J; Nasser S; Halperin R; et al. (PloS one, 2021)